Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway

Support Care Cancer. 2006 Dec;14(12):1173-83. doi: 10.1007/s00520-006-0097-7. Epub 2006 Jul 4.

Abstract

Introduction: Malnutrition is a common problem in cancer patients. Its incidence varies according to disease stage (between 15 and 90%) and is considered a possible prognostic factor for therapeutic response and survival. It is also one of the causes contributing to the increase in morbidity and mortality in patients. Tumor cachexia is defined as a nutritional defect caused by tumor growth in the patient and presents as a significant weight loss. This weight loss is mainly caused by a degradation of skeletal muscle proteins.

Conclusion: The ubiquitin-proteasome system is the most important pathway of protein degradation. As a regulatory system governing protein half-life, it is involved in the regulation of the cell cycle, signal transmission, immune system response, apoptosis, and oncogenesis. Knowledge of the molecular pathways involved in the induction of cancer-associated cachexia will favor a more rational approach to its treatment as well as possible quality of life and survival benefit for the patient.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anorexia / etiology*
  • Cachexia / etiology*
  • Humans
  • Neoplasms / complications*
  • Proteasome Endopeptidase Complex / physiology*
  • Proteoglycans / physiology
  • Signal Transduction / physiology
  • Syndrome
  • Tumor Necrosis Factor-alpha / physiology
  • Ubiquitin / metabolism*

Substances

  • Proteoglycans
  • Tumor Necrosis Factor-alpha
  • Ubiquitin
  • proteolysis-inducing peptide
  • Proteasome Endopeptidase Complex